Table 1. Main characteristics of eligible studies in this meta-analysis.
Author names | Years | Areas | Ethnicity | Genotyping method | Cases/controls | Cases | Controls | HWE | Association observed | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | CC | CT | TT | ||||||||
Nexo et al. [26] | 2003 | Denmark | Caucasian | TaqMan | 415/414 | 53 | 176 | 186 | 69 | 183 | 162 | YES | No risk |
Lee et al. [27] | 2005 | Korea | Asian | MALDI-TOF | 705/550 | 411 | 257 | 37 | 323 | 187 | 40 | YES | No risk |
Yang et al. [28] | 2013 | China | Asian | TaqMan | 461/504 | 183 | 166 | 112 | 232 | 184 | 88 | NO | TT genotype showed increased risk |
Zhu et al. [29] | 2015 | China | Asian | PCR-RFLP | 101/101 | 56 | 41 | 4 | 63 | 33 | 5 | YES | No risk |
Gomez-Diaz et al. [30] | 2015 | Mexico | Mexican-mestizo | TaqMan | 71/74 | 38 | 28 | 5 | 40 | 27 | 7 | YES | No risk |
He et al. [31] | 2016 | China | Asian | MALDI-TOF | 450/430 | 230 | 195 | 25 | 261 | 151 | 18 | YES | TT/TC genotype showed increased risk |
Pongsavee et al. [32] | 2017 | Thailand | Asian | TaqMan | 151/120 | 105 | 33 | 13 | 101 | 9 | 10 | NO | TT/TC genotype showed increased risk |
Abbreviation: PCR-RFLP, PCR-restriction fragment length polymorphism.